InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Browse the detailed record of transactions filed by Schwartz Phillip, Président de la R&D. Insider active across 1 company, notably Entera Bio Ltd.. Aggregated, 1 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €22k. Activity tracked since 20 January 2022. The latest transaction was disclosed on 20 January 2022 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Phillip Schwartz is the President of R&D at Entera Bio Ltd. He oversees the company's research and development initiatives focused on innovation in the biotechnology field. His technical expertise is crucial for developing new therapies and supporting Entera Bio's mission.